"Das Onkozentrum Zürich ist ein Gesundheitsunternehmen im Bereich ambulante und stationäre Onkologie."

During the past decade, Onkozentrum Hirslanden conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkozentrum Hirslanden" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Kantonsspital Aarau" with 1 trials as a collaborator, "Kantonsspital Münsterlingen" with 1 trials as a collaborator, "King's College London" with 1 trials as a collaborator and "Klinik Hirslanden, Zurich" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Onkozentrum Hirslanden" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Follicular Lymphoma" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Onkozentrum Hirslanden" in a lesser frequency.

Most popular intervention types in "Onkozentrum Hirslanden" are "Drug" (8 trials), "Biological" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Gemcitabine" (2 trials), "Bevacizumab, Cyclophosphamide, Capecitabine" (1 trials), "Cisplatin" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkozentrum Hirslanden" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Onkozentrum Hirslanden". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Onkozentrum Hirslanden, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Onkozentrum Hirslanden, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".